Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PROCEPT BioRobotics (PRCT) Work In Process (2024 - 2025)

PROCEPT BioRobotics (PRCT) has disclosed Work In Process for 2 consecutive years, with $12.8 million as the latest value for Q3 2025.

  • On a quarterly basis, Work In Process changed N/A to $12.8 million in Q3 2025 year-over-year; TTM through Sep 2025 was $12.8 million, a N/A change, with the full-year FY2024 number at $11.5 million, changed N/A from a year prior.
  • Work In Process was $12.8 million for Q3 2025 at PROCEPT BioRobotics, down from $13.0 million in the prior quarter.
  • In the past five years, Work In Process ranged from a high of $13.0 million in Q2 2025 to a low of $10.9 million in Q1 2025.